Chart of the Week: Number of concentrates product lines ballooning in Washington State

By Eli McVey

A surge in the number of concentrates product lines in Washington State’s recreational marijuana market attests to the growth in popularity of alternative consumption methods and highly potent cannabis, a trend seen across the industry at large.

According to retailer point-of-sale information provided by Headset, a Seattle-based cannabis industry data provider, the number of distinct concentrates product lines in Washington’s recreational market currently stands at 175, up from just 59 at this same time last year.

Month-to-month growth in the number of concentrates lines has been uneven, but over the past year the state is seeing an average of 10 new ones hit the market each month.

This proliferation of concentrates brands is reflective of underlying demand for the product.

In June of 2015, sales of concentrates accounted for 5.1% of Washington’s total marijuana sales. Now, they account for 8.3%.

Strong growth in concentrates sales is also being observed in Colorado, the nation’s largest recreational marijuana market. And now that Oregon is allowing recreational sales of concentrates – they were previously confined to the medical cannabis sector – look for a similar spike in this product category there.

Relative to traditional flower, concentrates have properties that are increasingly meeting a wide array of consumer preferences. High THC content attracts users that prefer dabbing, while their use in vape pens, perceived as a healthier and more discrete alternative to smoking, has wide appeal.

Jessica Henson, lead market analyst at Headset, points out that many concentrate brands produce their own artisanal concentrate with a consistency unique to their brand. She believes that as the consumer becomes more knowledgeable about extraction methods and terpene/cannabinoid profiles there will be a huge spike in these “house concentrates.”

Looking forward, the number of concentrates product lines is likely to continue to grow – both in Washington State and other markets.

Eli McVey can be reached at [email protected]

8 comments on “Chart of the Week: Number of concentrates product lines ballooning in Washington State
    • John on

      So the thousands of years of humans consuming hashish is now equivalent to smoking crack just because you don’t like the modern toolkit used to partake? This is and has been the SOLE method of consumption for many cultures. Please educate yourself before you make jabs at a topic you clearly have no historical knowledge of.

      Reply
    • Johnny on

      The same distillation process used for providing high-THC content concentrates is also being used for other cannabinoid/terpenoid benefits. This means more effective medicine for those who need it.

      Reply
  1. Saul Immanuel on

    Actually John, you are misinformed.

    Even just 30 years ago, Hashish from major production centers in Morocco, Afghanistan, Kazakhstan or Nepal, for example, has tended to run <20% THC, with all other cannabinoids and terpenes intact, drawn from source material the predates 50 years of breeding in the illicit underground for maximum narcotic potency and yield. That means cannabis with THC percentages averaging 4-10% taken and rubbed by hand over screens, or some other solventless process, which increases dramatically the non-cannabinoid constituents left behind such as waxes and leaf/flower material, leaving a THC concentration somewhere lower than the average flower sold in medical dispensaries.

    As for Johhny – you are wrong as well. More is not always better. There is a substantial amount of research that indicates that your body shuts down cannabinoid receptors when exposed to the concentration of THC, etc. that you are celebrating. That means your medicine eventually stops working unless you feed yourself ever-increasing concentrations of cannabinoids. There are clinics now that provide incredibly effective cannabis therapy with low, weekly doses. Fact is, there is an emerging body of research that indicates cannabis is MUCH MORE EFFECTIVE as medicine at LOWER, LESS FREQUENT doses.

    Someday soon all these cornball folk tales y'all are cashing in on will disintegrate in the face of real information, real science, real facts. The DEA, FDA and other federal agencies are deliberating at this very moment about regulatory structures that will be required to accommodate the rescheduling of cannabis and the advent of commercial-scale, industrial production. Among the things being discussed in earnest is harm reduction. That begins with a basic understanding of how this all works, and how this plant affects the human body. Dabs are bad for people. Plain and simple.

    If you want to encounter some real knowledge on the subject – and not some ignorant, lazy, cheerleader pap presented as journalism – do your own research. It's everywhere, and most of it is free. If you actually cared about cannabis and the people who need it, you would already know all this.

    Class dismissed.

    Reply
      • Saul Immanuel on

        Only to greedy, ignorant lil crabs that seem hellbent on using misinformation to promote cannabis products that hurt people. Subverting evil people is called ‘heroic’, even if it’s also rude.

        Reply
  2. bongstar420 on

    As growers realize they suck, they start producing more concentrates and edibles.

    Too bad those markets rightfully belong to good growers as well.

    It just so happens that low skilled rich people can actually compete with good growers in concentrates and edibles but not fine flowers

    Reply
    • Saul Immanuel on

      This is TOTALLY the case. Rather than admit they were overly ambitious and underskilled and go back to flipping real estate, they make weedcrack.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *